title: The dose of total body irradiation (TBI), and GvHD prophilaxis have a crucial role on relapse risk and survival after BMT for leukaemia.
authors.affiliation: Centro Trapianti Midollo Osseo, Divisione Ematologia, Genova, Italy.
authors.forename: F
authors.initials: F
authors.lastname: Frassoni
authors.forename: A
authors.initials: A
authors.lastname: Bacigalupo
authors.forename: M
authors.initials: M
authors.lastname: Sessarego
authors.forename: F
authors.initials: F
authors.lastname: Gualandi
authors.forename: T
authors.initials: T
authors.lastname: Lamparelli
authors.forename: M T
authors.initials: MT
authors.lastname: Van Lint
authors.forename: D
authors.initials: D
authors.lastname: Occhini
authors.forename: R
authors.initials: R
authors.lastname: Corvò
authors.forename: D
authors.initials: D
authors.lastname: Scarpati
authors.forename: V
authors.initials: V
authors.lastname: Vitale
mesh_terms: D016026:Bone Marrow Transplantation / Q000379:methods* / Q000401:mortality; D003520:Cyclophosphamide / Q000627:therapeutic use; D003524:Cyclosporins / Q000008:administration & dosage / Q000627:therapeutic use; D006086:Graft vs Host Disease / Q000401:mortality / Q000517:prevention & control*; D006801:Humans; D007558:Italy / Q000453:epidemiology; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000401:mortality / Q000601:surgery*; D015470:Leukemia, Myeloid, Acute / Q000401:mortality / Q000601:surgery*; D008727:Methotrexate / Q000627:therapeutic use; D009364:Neoplasm Recurrence, Local / Q000453:epidemiology; D011446:Prospective Studies; D011879:Radiotherapy Dosage; D012307:Risk Factors; D015996:Survival Rate; D014916:Whole-Body Irradiation / Q000401:mortality
chemical_list: D003524:Cyclosporins; D003520:Cyclophosphamide; D008727:Methotrexate